Adverum Biotechnologies Inc (NASDAQ:ADVM)
| 0.7857 BATS BZX Real-Time Price As of 11:56am ET |  -0.0358 / -4.36%Today’s Change | 0.53 Today|||52-Week Range 1.82 | +35.58% Year-to-Date |
Latest ADVM News | Press Releases
No recent news for Adverum Biotechnologies Inc.
Today’s Trading
| Previous close | 0.82 |
| Today’s open | 0.77 |
| Day’s range | 0.77 - 0.79 |
| Volume | 600 |
| Average volume (3 months) | 538,710 |
| Market cap | $83.8M |
Data as of 11:56am ET, 03/20/2023
Growth & Valuation
| Earnings growth (last year) | -7.56% |
| Earnings growth (this year) | -7.60% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 23.01 |
| Price/Book | 0.26 |
Competitors
Data as of 12:07pm ET, 03/20/2023
Financials
| Last reporting date | March 20, 2023 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $7.5M |
| Annual profit (last year) | -$145.5M |
| Net profit margin | -1,940.53% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
